Literature DB >> 31819272

Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.

Dirksen E Bussiere1, Lili Xie2, Honnappa Srinivas3, Wei Shu2, Ashley Burke4, Celine Be3, Junping Zhao4, Adarsh Godbole4, Dan King4, Rajeshri G Karki4, Viktor Hornak4, Fangmin Xu4, Jennifer Cobb4, Nathalie Carte3, Andreas O Frank2, Alexandra Frommlet2, Patrick Graff3, Mark Knapp2, Aleem Fazal4, Barun Okram5, Songchun Jiang5, Pierre-Yves Michellys5, Rohan Beckwith4, Hans Voshol3, Christian Wiesmann3, Jonathan M Solomon6, Joshiawa Paulk7.   

Abstract

The anticancer agent indisulam inhibits cell proliferation by causing degradation of RBM39, an essential mRNA splicing factor. Indisulam promotes an interaction between RBM39 and the DCAF15 E3 ligase substrate receptor, leading to RBM39 ubiquitination and proteasome-mediated degradation. To delineate the precise mechanism by which indisulam mediates the DCAF15-RBM39 interaction, we solved the DCAF15-DDB1-DDA1-indisulam-RBM39(RRM2) complex structure to a resolution of 2.3 Å. DCAF15 has a distinct topology that embraces the RBM39(RRM2) domain largely via non-polar interactions, and indisulam binds between DCAF15 and RBM39(RRM2), coordinating additional interactions between the two proteins. Studies with RBM39 point mutants and indisulam analogs validated the structural model and defined the RBM39 α-helical degron motif. The degron is found only in RBM23 and RBM39, and only these proteins were detectably downregulated in indisulam-treated HCT116 cells. This work further explains how indisulam induces RBM39 degradation and defines the challenge of harnessing DCAF15 to degrade additional targets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31819272     DOI: 10.1038/s41589-019-0411-6

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  47 in total

1.  Recognition of the polyubiquitin proteolytic signal.

Authors:  J S Thrower; L Hoffman; M Rechsteiner; C M Pickart
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

Review 2.  Enzymes of ubiquitination and deubiquitination.

Authors:  Melanie Neutzner; Albert Neutzner
Journal:  Essays Biochem       Date:  2012       Impact factor: 8.000

Review 3.  The demographics of the ubiquitin system.

Authors:  Michael J Clague; Claire Heride; Sylvie Urbé
Journal:  Trends Cell Biol       Date:  2015-04-21       Impact factor: 20.808

Review 4.  Ubiquitin Ligases: Structure, Function, and Regulation.

Authors:  Ning Zheng; Nitzan Shabek
Journal:  Annu Rev Biochem       Date:  2017-03-27       Impact factor: 23.643

Review 5.  Recognition of Client Proteins by the Proteasome.

Authors:  Houqing Yu; Andreas Matouschek
Journal:  Annu Rev Biophys       Date:  2017-03-09       Impact factor: 12.981

Review 6.  Targeted protein degradation by PROTACs.

Authors:  Taavi K Neklesa; James D Winkler; Craig M Crews
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

Review 7.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

8.  Structural basis for an unexpected mode of SERM-mediated ER antagonism.

Authors:  Ya-Ling Wu; Xiaojing Yang; Zhong Ren; Donald P McDonnell; John D Norris; Timothy M Willson; Geoffrey L Greene
Journal:  Mol Cell       Date:  2005-05-13       Impact factor: 17.970

Review 9.  Gates, Channels, and Switches: Elements of the Proteasome Machine.

Authors:  Daniel Finley; Xiang Chen; Kylie J Walters
Journal:  Trends Biochem Sci       Date:  2015-11-28       Impact factor: 13.807

Review 10.  Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

Authors:  Ian Collins; Hannah Wang; John J Caldwell; Raj Chopra
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

View more
  36 in total

1.  Recent molecular insights into canonical pre-mRNA 3'-end processing.

Authors:  Yadong Sun; Keith Hamilton; Liang Tong
Journal:  Transcription       Date:  2020-06-11

2.  Molecular glue concept solidifies.

Authors:  Kheewoong Baek; Brenda A Schulman
Journal:  Nat Chem Biol       Date:  2020-01       Impact factor: 15.040

Review 3.  Proteolysis-targeting chimeras in drug development: A safety perspective.

Authors:  Kevin Moreau; Muireann Coen; Andrew X Zhang; Fiona Pachl; M Paola Castaldi; Goran Dahl; Helen Boyd; Clay Scott; Pete Newham
Journal:  Br J Pharmacol       Date:  2020-02-25       Impact factor: 8.739

4.  Mechanistic and Structural Features of PROTAC Ternary Complexes.

Authors:  Ryan Casement; Adam Bond; Conner Craigon; Alessio Ciulli
Journal:  Methods Mol Biol       Date:  2021

5.  Rational discovery of molecular glue degraders via scalable chemical profiling.

Authors:  Sophie Bauer; Matthias Brand; Cristina Mayor-Ruiz; Zuzanna Kozicka; Marton Siklos; Hana Imrichova; Ines H Kaltheuner; Elisa Hahn; Kristina Seiler; Anna Koren; Georg Petzold; Michaela Fellner; Christoph Bock; André C Müller; Johannes Zuber; Matthias Geyer; Nicolas H Thomä; Stefan Kubicek; Georg E Winter
Journal:  Nat Chem Biol       Date:  2020-08-03       Impact factor: 15.040

Review 6.  Chemical strategies to overcome resistance against targeted anticancer therapeutics.

Authors:  Rudolf Pisa; Tarun M Kapoor
Journal:  Nat Chem Biol       Date:  2020-07-21       Impact factor: 15.040

7.  Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation.

Authors:  Lu Lv; Peihao Chen; Longzhi Cao; Yamei Li; Zhi Zeng; Yue Cui; Qingcui Wu; Jiaojiao Li; Jian-Hua Wang; Meng-Qiu Dong; Xiangbing Qi; Ting Han
Journal:  Elife       Date:  2020-08-17       Impact factor: 8.140

Review 8.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Authors:  Tao Wu; Hojong Yoon; Yuan Xiong; Sarah E Dixon-Clarke; Radosław P Nowak; Eric S Fischer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

Review 9.  Evaluating and evolving a screening library in academia: the St Jude approach.

Authors:  Gisele Nishiguchi; Sourav Das; Jason Ochoada; Heather Long; Richard E Lee; Zoran Rankovic; Anang A Shelat
Journal:  Drug Discov Today       Date:  2021-01-14       Impact factor: 7.851

Review 10.  Advancing targeted protein degradation for cancer therapy.

Authors:  Brandon Dale; Meng Cheng; Kwang-Su Park; H Ümit Kaniskan; Yue Xiong; Jian Jin
Journal:  Nat Rev Cancer       Date:  2021-06-15       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.